STAT3 and Hepatic fibrosis: In conclusion, blocking Type I IFN signaling significantly alleviates liver fibrosis by modulating macrophage-derived STAT3 signaling, promoting anti-inflammatory responses, and supporting tissue repair and regeneration (Figure 8).